Supporting patient groups and continuously improving knowledge in our therapy areas is part of our corporate responsibility.
Our ultimate goal is to discover and develop innovative therapies to improve patients' quality of life.
We specialize in the treatment of life-threatening diseases. Our patients always come first.
We offer programs for patients, families and patient organizations worldwide. They help to improve the quality of medical care.
Welcome to CSL Innovation GmbH, the Research & Development team in Marburg.
We actively promote collaborations and partnerships to bring innovation to patients.
At CSL Behring, we work every day as if someone’s life depends on it, because it does.
CSL Behring's biotherapeutics are manufactured in state-of-the-art facilities under strictly controlled conditions.
Help us deliver on our promise to save lives and protect the health of people.
We want you to feel comfortable at CSL.
Get to know us and learn more about people, projects and what happens in the world of CSL Behring.
Information for the press, such as press releases and press contact.
Popular search terms:
On Word Hemophilia Day we reaffirm our mission to create best-in-calss treatments for haemophilia
More than a century of scientific research and discovery
EMA Commences Review of Novel Gene Therapy Candidate Etranacogene Dezaparvovec for People with Hemophilia B
Under the motto "Share Your Colors", we are setting an example for the 300 million people living with a rare disease.
We chatted with mother-and-son team Evren and Kara Ayik, authors of a new book that’s for, and about, kids who have rare dise…
Supporters hope a newly adopted U.N. resolution will make rare disease patients more visible and ensure they have access to c…
Hesse’s Minister of Economics Tarek Al-Wazir was deeply impressed at the award ceremony.
On 3 December, buildings around the world are shining in purple – also at CSL Behring in Marburg.
On 26 and 27 October 2021, Paul Perreault, CEO of CSL Limited was welcomed to the Marburg site.
Americas
Asia Pacific
Middle East
Europe
